Hua HY et al. |
High-performance liquid chromatographic and pharmacokinetic analyses of an intravenous submicron emulsion of perillyl alcohol in rats. |
2008 |
J Pharm Biomed Anal |
pmid:18849133
|
Bailey HH et al. |
Phase II trial of daily oral perillyl alcohol (NSC 641066) in treatment-refractory metastatic breast cancer. |
2008 |
Cancer Chemother. Pharmacol. |
pmid:17885756
|
da Fonseca CO et al. |
Preliminary results from a phase I/II study of perillyl alcohol intranasal administration in adults with recurrent malignant gliomas. |
2008 |
Surg Neurol |
pmid:18295834
|
Stratton SP et al. |
Phase 1 study of topical perillyl alcohol cream for chemoprevention of skin cancer. |
2008 |
Nutr Cancer |
pmid:18444166
|
Bhatia SP et al. |
Fragrance material review on p-mentha-1,8-dien-7-ol. |
2008 |
Food Chem. Toxicol. |
pmid:18640209
|
Lebedeva IV et al. |
Chemoprevention by perillyl alcohol coupled with viral gene therapy reduces pancreatic cancer pathogenesis. |
2008 |
Mol. Cancer Ther. |
pmid:18645014
|
Lebedeva IV et al. |
Mechanism of in vitro pancreatic cancer cell growth inhibition by melanoma differentiation-associated gene-7/interleukin-24 and perillyl alcohol. |
2008 |
Cancer Res. |
pmid:18768668
|
da Fonseca CO et al. |
Ras pathway activation in gliomas: a strategic target for intranasal administration of perillyl alcohol. |
2008 Jul-Aug |
Arch. Immunol. Ther. Exp. (Warsz.) |
pmid:18726148
|
Chaudhary SC et al. |
Perillyl alcohol attenuates Ras-ERK signaling to inhibit murine skin inflammation and tumorigenesis. |
2009 |
Chem. Biol. Interact. |
pmid:19161993
|
Kim D and Ortiz de Montellano PR |
Tricistronic overexpression of cytochrome P450cam, putidaredoxin, and putidaredoxin reductase provides a useful cell-based catalytic system. |
2009 |
Biotechnol. Lett. |
pmid:19458919
|